dre; mris; psa; prostate cancer

A common question in our comments section is whether the digital rectal exam (DRE), also known as the "finger test," is still relevant in 2023. Here, medical oncologist Mark Scholz, MD, argues that the DRE is low-risk and still valuable because it can catch low-PSA-producing cancers that would...